Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ER Torsemide vs Demadex in Healthy Adults
NCT03214874Phase 1Completed
- Start
- Jun 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of torasemide in heart failure (HF) and chronic kidney disease (CKD) (2 arms). Primary endpoints: Peak plasma concentration at 24 hours, Total plasma concentration at 24 hours and 1 more. Started Jun 2017; status: completed.
02
Drugs
torasemide
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03214874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214874.